1Kuchulakanti P,Chu W,Torguson R,et al.Correlates and long term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel eluting stents.Circulation,2006,113:1108-1113.
2Luscher TF,Steffel J,Eberli FR,et al.Drug-eluting stent and coronary thrombosis:Biological mechanisms and clinical implications.Circulation,2007,115:1051-1058.
3Kotani JI,Awata M,Nanto S,et al.Incomplete neointimal coverage of sirolimus eluting stents:Angioscopic findings.J Am Coll Cardiol,2006,47:2108-2111.
4Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293:2126-2130.
5Virmani R,Guagliumi G,Farb A,et al.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent:Should we be cautious? Circulation,2004,109:701-705.
6Lee MS,Jurewitz D,Aragon J,et al.Stent fracture associated with drug-eluting stents:Clinical characteristics and implications.Catheter Cardiovasc Interv,2007,69:387-394.
4Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
5Daemen J,Wenaweser P,Tsuchida K,et al.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:data from a large two-institutional cohort study[J].Lancet,2007,369(9562):667-678.
6Pinto Slottow TL,Steinberg DH,Roy PK,et al.Observations and outeomee of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period[J].Am J Cardiol,2008,102(3):298-303.